Orchestra BioMed Holdings, Inc.OBIONASDAQ

Revenue (LTM)

$33M

+1169.2% YoY

Net Income (LTM)

$-53M

+13.2% YoY

Free Cash Flow

$-49M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	-1	4↑551.8%	3↓21.9%	3↓4.4%	33↑1169.2%
Gross Profit	-1	3↑427.3%	3↓19.8%	2↓5.4%	33↑1267.8%
Operating Income	-22	-33↓49.8%	-52↓57.7%	-64↓24.8%	-52↑19.4%
Net Income	-23	-34↓46.0%	-49↓46.2%	-61↓24.2%	-53↑13.2%
EBITDA	-22	-32↓50.0%	-51↓57.9%	-64↓24.9%	-51↑19.6%
EPS Diluted	-0.02	-1.32↓7035.1%	-1.48↓12.1%	-1.66↓12.2%	-1.11↑33.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	10	20↑99.1%	31↑54.5%	22↓27.2%	35↑55.8%
Total Current Assets	11	85↑648.2%	89↑5.2%	69↓22.4%	108↑56.0%
Total Assets	14	96↑606.5%	95↓0.4%	76↓20.0%	115↑50.8%
Total Current Liabilities	12	19↑51.7%	11↓39.6%	16↑44.6%	17↑3.3%
Total Liabilities	85	43↓49.2%	27↓36.9%	43↑59.1%	51↑19.1%
Total Equity	-71	53↑173.8%	68↑29.5%	33↓51.6%	63↑92.3%
Total Debt	6	12↑109.2%	2↓85.8%	17↑879.8%	2↓89.8%
Net Debt	-4	-8↓85.6%	-29↓264.8%	-6↑80.1%	-33↓475.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-19	-29↓50.7%	-46↓57.5%	-51↓9.6%	-49↑3.2%
Capital Expenditure	-0	-1↓115.7%	-0↑86.8%	-0↓270.5%	-0↓69.2%
Free Cash Flow	-20	-30↓51.7%	-46↓54.6%	-51↓10.0%	-49↑2.7%
Stock-Based Comp	0	3↑1030.1%	8↑123.4%	11↑39.2%	12↑12.8%
Net Change in Cash	-10	10↑194.6%	11↑9.4%	-8↓177.0%	12↑249.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance